SMTL ID : 8via.1

Protective effect of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-1-1-mer

Ligands

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 5 residues within 4Å: Chain A: G.325, E.326, N.329, A.330, S.357 No protein-ligand interaction detected (PLIP)

2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 2 residues within 4Å: Chain A: N.317, Q.566 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:Q.566 NAG.3: 2 residues within 4Å: Chain A: N.602, T.604 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.602, A:T.604

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Clark, J. et al., Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination. Biorxiv (2024)

Release Date

2024-10-23

Peptides

Spike protein S1: A
Spike protein S2: B
PVI.V5-4 heavy chain: C
PVI.V5-4 light chain: D

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

B
C

C
H

D
L

Spike protein S1

Spike protein S2

PVI.V5-4 heavy chain

PVI.V5-4 light chain